이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Zevra Therapeutics 관리
관리 기준 확인 0/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Neil McFarlane
최고 경영자
US$3.4m
총 보상
| CEO 급여 비율 | 4.6% |
| CEO 임기 | less than a year |
| CEO 소유권 | n/a |
| 경영진 평 균 재임 기간 | 1.4yrs |
| 이사회 평균 재임 기간 | 1.2yrs |
최근 관리 업데이트
Recent updates
Analysts Just Shaved Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Forecasts Dramatically
Apr 07
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 04Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors
Apr 02Investors Appear Satisfied With Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Prospects
Dec 28Bullish: Analysts Just Made A Noticeable Upgrade To Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Forecasts
Sep 05This Just In: Analysts Are Boosting Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Outlook for This Year
Aug 20Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
Apr 17US$18.00: That's What Analysts Think Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Is Worth After Its Latest Results
Mar 10Is Zevra Therapeutics (NASDAQ:ZVRA) Using Debt In A Risky Way?
Mar 08Bearish: Analysts Just Cut Their KemPharm, Inc. (NASDAQ:KMPH) Revenue and EPS estimates
Nov 16Does KemPharm (NASDAQ:KMPH) Have A Healthy Balance Sheet?
Nov 11KemPharm posts Phase 1 data to support further studies for sleep disorder therapy
Sep 28KemPharm wins Buy rating at Canaccord on CNS focus
Sep 15KemPharm - Redesigning Approved Drugs For Better Efficacy And Safety
Jun 28KemPharm exercises existing warrants and issues new ones in private placement
Jun 18KemPharm reports orange book listing for six U.S. patents covering serdexmethylphenidate
May 26CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$49m |
| Dec 31 2023 | US$3m | US$158k | -US$46m |
보상 대 시장: Neil 의 총 보상 ($USD 3.45M )은 US 시장( $USD 1.62M ).
보상과 수익: Neil 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.
CEO
Neil McFarlane (51 yo)
less than a year
테뉴어
US$3,445,231
보상
Mr. Neil F. McFarlane serves as President & Chief Executive Officer at Zevra Therapeutics, Inc. since October 10, 2023 and serves as its Director since October 9, 2023. He has served as Director at Collegi...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | less than a year | US$3.45m | 데이터 없음 | |
| Co-Founder & Chief Development Officer | no data | US$1.67m | 0.065% $ 124.9k | |
| CFO, Secretary & Treasurer | 9yrs | US$2.26m | 0.038% $ 72.9k | |
| Chief Commercial Officer & Executive VP of Business Development | 1.4yrs | US$1.82m | 0.0084% $ 16.1k | |
| Chief Scientific Officer | 1.4yrs | US$1.08m | 0.0066% $ 12.6k | |
| Vice President of Investor Relations & Corporate Communications | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Manufacturing | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Clinical Development | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Medical Affairs & Advocacy | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior VP & Corporate Controller | 7.3yrs | 데이터 없음 | 0.011% $ 20.4k |
1.4yrs
평균 재임 기간
51.5yo
평균 연령
경험이 풍부한 관리: ZVRA 의 관리팀은 경험 (평균 재직 기간 1.4 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | less than a year | US$3.45m | 데이터 없음 | |
| Independent Director | 1.2yrs | US$274.00k | 0% $ 0 | |
| Independent Director | 1.2yrs | US$258.02k | 0% $ 0 | |
| Independent Chair | 2.8yrs | US$324.39k | 0.0017% $ 3.3k | |
| Member of Scientific and Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 1.2yrs | US$264.31k | 0.048% $ 91.8k | |
| Independent Director | 1.2yrs | US$260.67k | 0.0024% $ 4.6k | |
| Chairman of Scientific and Medical Advisory Board | 17.4yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific & Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Co-Chair of Physician Advisory Council | 10.7yrs | 데이터 없음 | 데이터 없음 | |
| Co-Chair of Physician Advisory Council | 10.7yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | less than a year | US$243.04k | 0.024% $ 45.9k |
1.2yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 이사회: ZVRA 의 이사회는 경험(평균 재직 기간 1.2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.